Insulet
PODD
#1841
Rank
NZ$19.57 B
Marketcap
NZ$282.56
Share price
3.34%
Change (1 day)
-40.49%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): NZ$0.80 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$2.90 Billion. In 2025 the company made an earning of NZ$0.68 Billion, an increase over its 2024 earnings that were of NZ$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.80 B17.22%
2025 NZ$0.68 B16.3%
2024 NZ$0.59 B36.76%
2023 NZ$0.43 B481.9%
2022 NZ$74.4 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$94.77 M18.51%
2019 NZ$79.97 M41.16%
2018 NZ$56.65 M-711.95%
2017 -NZ$9.26 Million-56.85%
2016 -NZ$21.46 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$63.31 Million31.04%
2013 -NZ$48.32 Million-21.96%
2012 -NZ$61.92 Million
2010 -NZ$59.05 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$92.96 Million209.75%
2006 -NZ$30.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.85 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.04 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$11.82 B 1,360.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$53.73 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.17 Billion-120.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.16 B-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$2.10 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA